Israeli Life Sciences Investments Surge to USD 2.7B
Investment in Israel’s life sciences and health-tech industries surged 25% in 2024, reaching USD 2.7 billion, according to a report from the Israeli Advanced Technology Industries (IATI), the Israel Innovation Authority, and PwC Israel. The growth was fueled by increased funding for rehabilitation and medical infrastructure, particularly in response to the Israel-Hamas War.
The report, released ahead of the MIXiii Health-Tech.IL conference in Jerusalem, also highlights a resurgence of Israeli companies going public on U.S. stock exchanges, with four IPOs in 2024 compared to none the previous year. Karin Mayer Rubinstein, CEO and President of IATI, emphasized Israel’s innovation ecosystem as a symbol of resilience and adaptability in turning challenges into opportunities.
Read more in the Jerusalem Post.
